ARCHIVES

Cancer & The Media: Klausner, Watson Dispute Comments In New York Times Story

This article is from The Cancer Letter archive.

Vol. 24 No. 18 | May 8, 1998

Download PDF Visit The Full Archive

Related Articles

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

Overhead Caused By Outreach, Other Federal Programs Threatens Cancer Centers, Durant Contends

November 5, 1976

McDonald’s Charity Commits $5 Million To Pediatric Research

May 17, 1991

In Brief: Kripke, Fidler To Leave FCRF for M.D. Anderson; George Todaro Takes Job With New Seattle Firm

March 4, 1983